LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Neratinib | 0.56234 | 90.55 | 27.76 | 360 | 6928 | 0.0520 | 0.3796 | MN20160318_Q01 | L13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.56234 | 90.55 | 27.76 | 1585 | 6928 | 0.2288 | 0.6618 | MN20160318_Q01 | L13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.56234 | 92.25 | 27.76 | 1 | 6873 | 0.0001 | -0.3416 | MN20160318_Q01 | L11 |
| MCF 10A-H2B-mCherry | Neratinib | 0.56234 | 92.25 | 27.76 | 941 | 6873 | 0.1369 | 0.5575 | MN20160318_Q01 | L11 |
| MCF 10A-H2B-mCherry | Neratinib | 0.56234 | 92.25 | 27.76 | 398 | 6873 | 0.0579 | 0.3978 | MN20160318_Q01 | L13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.56234 | 92.25 | 27.76 | 1655 | 6873 | 0.2408 | 0.6721 | MN20160318_Q01 | L13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.56234 | 93.96 | 27.76 | 1 | 6849 | 0.0001 | -0.3418 | MN20160318_Q01 | L11 |
| MCF 10A-H2B-mCherry | Neratinib | 0.56234 | 93.96 | 27.76 | 931 | 6849 | 0.1359 | 0.5559 | MN20160318_Q01 | L11 |
| MCF 10A-H2B-mCherry | Neratinib | 0.56234 | 93.96 | 27.76 | 391 | 6849 | 0.0571 | 0.3950 | MN20160318_Q01 | L13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.56234 | 93.96 | 27.76 | 1609 | 6849 | 0.2349 | 0.6668 | MN20160318_Q01 | L13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.56234 | 95.66 | 27.76 | 1 | 6712 | 0.0001 | -0.3428 | MN20160318_Q01 | L11 |
| MCF 10A-H2B-mCherry | Neratinib | 0.56234 | 95.66 | 27.76 | 910 | 6712 | 0.1356 | 0.5539 | MN20160318_Q01 | L11 |
| MCF 10A-H2B-mCherry | Neratinib | 0.56234 | 95.66 | 27.76 | 428 | 6712 | 0.0638 | 0.4127 | MN20160318_Q01 | L13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.56234 | 95.66 | 27.76 | 1618 | 6712 | 0.2410 | 0.6711 | MN20160318_Q01 | L13 |
| MCF 10A-H2B-mCherry | Neratinib | 1 | 1.95 | 27.76 | 2 | 225 | 0.0089 | -0.5815 | MN20160318_Q01 | E14 |
| MCF 10A-H2B-mCherry | Neratinib | 1 | 1.95 | 27.76 | 537 | 225 | 2.3852 | 1.6671 | MN20160318_Q01 | E14 |
| MCF 10A-H2B-mCherry | Neratinib | 1 | 1.95 | 27.76 | 1 | 225 | 0.0044 | -0.6673 | MN20160318_Q01 | H08 |
| MCF 10A-H2B-mCherry | Neratinib | 1 | 1.95 | 27.76 | 13 | 225 | 0.0577 | -0.2221 | MN20160318_Q01 | H08 |
| MCF 10A-H2B-mCherry | Neratinib | 1 | 3.66 | 27.76 | 1 | 283 | 0.0035 | -0.6287 | MN20160318_Q01 | E14 |
| MCF 10A-H2B-mCherry | Neratinib | 1 | 3.66 | 27.76 | 552 | 283 | 1.9442 | 1.4384 | MN20160318_Q01 | E14 |
| MCF 10A-H2B-mCherry | Neratinib | 1 | 3.66 | 27.76 | 1 | 283 | 0.0035 | -0.6287 | MN20160318_Q01 | H08 |
| MCF 10A-H2B-mCherry | Neratinib | 1 | 3.66 | 27.76 | 13 | 283 | 0.0458 | -0.2024 | MN20160318_Q01 | H08 |
| MCF 10A-H2B-mCherry | Neratinib | 1 | 5.36 | 27.76 | 2 | 320 | 0.0062 | -0.5255 | MN20160318_Q01 | E14 |
| MCF 10A-H2B-mCherry | Neratinib | 1 | 5.36 | 27.76 | 551 | 320 | 1.7200 | 1.3322 | MN20160318_Q01 | E14 |
| MCF 10A-H2B-mCherry | Neratinib | 1 | 5.36 | 27.76 | 1 | 320 | 0.0031 | -0.6101 | MN20160318_Q01 | H08 |